These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27112673)

  • 1. Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
    Popescu BF; Lucchinetti CF
    Handb Clin Neurol; 2016; 133():95-106. PubMed ID: 27112673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
    Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
    Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NMO spectrum disorders and anti AQP4 antibody].
    Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients.
    Matsuoka T; Suzuki SO; Suenaga T; Iwaki T; Kira J
    Brain Pathol; 2011 Sep; 21(5):516-32. PubMed ID: 21241398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
    Hinson SR; Lennon VA; Pittock SJ
    Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathology of multiple sclerosis and neuromyelitis optica].
    Masaki K
    Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early disruption of glial communication via connexin gap junction in multiple sclerosis, Baló's disease and neuromyelitis optica.
    Masaki K
    Neuropathology; 2015 Oct; 35(5):469-80. PubMed ID: 26016402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
    Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
    Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What I have learned and accomplished through research on multiple sclerosis (MS)].
    Itoyama Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):699-707. PubMed ID: 20030191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
    Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
    J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
    Yoshida M
    Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.
    Haruki H; Sano Y; Shimizu F; Omoto M; Tasaki A; Oishi M; Koga M; Saito K; Takahashi T; Nakada T; Kanda T
    J Neurol Sci; 2013 Aug; 331(1-2):136-44. PubMed ID: 23809190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.